Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Cancer Lett. 2018 Nov 14;442:333–340. doi: 10.1016/j.canlet.2018.11.007

Fig. 2. HHLA2 is overexpressed in adenocarcinoma.

Fig. 2.

Representative sample of each score showing variable HHLA2 IHC staining. HHLA2 IHC expression scoring: score 0 (0%), score 1 (1%~5%), score 2 (6%~30%), score 3 (31%~60%), score 4 (61%~100%). H&E staining and HHLA2 IHC from the same section of the TMA core are presented. Scale bar, 500um. Magnification, 200x.